Amgen
Amgen announced a collaboration with Adaptive Biotechnologies to combine expertise to discover and develop fully human neutralizing antibodies targeting SARS-CoV-2 to potentially prevent or treat COVID-19
Rankings by
National Ranking131st
in United States Regional Ranking141st
in North America and Caribbean Global Ranking343rd
worldwide